204 related articles for article (PubMed ID: 3469936)
21. Treatment of acute lymphoblastic leukemia in children. Long-term results of two trials.
Cáp J; Koza I; Misíková Z; Foltinová A; Strbáková E
Neoplasma; 1983; 30(1):81-92. PubMed ID: 6339961
[TBL] [Abstract][Full Text] [Related]
22. [Treatment of relapse in acute lymphoblastic leukaemia of childhood (author's transl)].
Creutzig U; Schellong G
Dtsch Med Wochenschr; 1980 Aug; 105(32):1109-12. PubMed ID: 6933063
[TBL] [Abstract][Full Text] [Related]
23. Analysis of treatment in childhood leukaemia. II. Timing and the toxicity of combined 6-mercaptopurine and methotrexate maintenance therapy.
MacLennan IC; Kay HE; Festenstein M; Smith PG
Br J Haematol; 1976 Jun; 33(2):179-88. PubMed ID: 1063593
[TBL] [Abstract][Full Text] [Related]
24. Intermediate-dose intravenous methotrexate with intravenous mercaptopurine is superior to repetitive low-dose oral methotrexate with intravenous mercaptopurine for children with lower-risk B-lineage acute lymphoblastic leukemia: a Pediatric Oncology Group phase III trial.
Mahoney DH; Shuster J; Nitschke R; Lauer SJ; Winick N; Steuber CP; Camitta B
J Clin Oncol; 1998 Jan; 16(1):246-54. PubMed ID: 9440749
[TBL] [Abstract][Full Text] [Related]
25. Physician compliance and relapse rates of acute lymphoblastic leukemia in children.
Peeters M; Koren G; Jakubovicz D; Zipursky A
Clin Pharmacol Ther; 1988 Mar; 43(3):228-32. PubMed ID: 3162210
[TBL] [Abstract][Full Text] [Related]
26. Treatment of adult lymphoblastic leukaemia using cyclical chemotherapy with three combinations of four drugs (COAP, POMP, TRAP schedule).
Proctor SJ; Finney R; Walker W; Thompson RB
Postgrad Med J; 1981 Jan; 57(663):19-22. PubMed ID: 6944694
[TBL] [Abstract][Full Text] [Related]
27. Methotrexate-induced malabsorption in children with acute lymphoblastic leukaemia.
Craft AW; Kay H; Lawson DN; McElwain TJ
Br Med J; 1977 Dec; 2(6101):1511-2. PubMed ID: 271033
[TBL] [Abstract][Full Text] [Related]
28. Can food influence the absorption of methotrexate in children with acute lymphoblastic leukaemia?
Pinkerton CR; Welshman SG; Glasgow JF; Bridges JM
Lancet; 1980 Nov; 2(8201):944-6. PubMed ID: 6107590
[TBL] [Abstract][Full Text] [Related]
29. Methotrexate bioavailability after oral and intramuscular administration in children.
Teresi ME; Crom WR; Choi KE; Mirro J; Evans WE
J Pediatr; 1987 May; 110(5):788-92. PubMed ID: 3471936
[TBL] [Abstract][Full Text] [Related]
30. [Combination chemotherapy of acute lymphoid leukaemia in children combined with prophylactic cranial irradiation (author's transl)].
Gröbe H; Schellong G; Wannenmacher
Dtsch Med Wochenschr; 1977 Jan; 102(2):49-54. PubMed ID: 264284
[TBL] [Abstract][Full Text] [Related]
31. Randomized comparison of moderate-dose methotrexate infusions to oral methotrexate in children with intermediate risk acute lymphoblastic leukemia: a Childrens Cancer Group study.
Lange BJ; Blatt J; Sather HN; Meadows AT
Med Pediatr Oncol; 1996 Jul; 27(1):15-20. PubMed ID: 8614385
[TBL] [Abstract][Full Text] [Related]
32. Acute lymphocytic leukemia in children: maintenance therapy with methotrexat administered intermittently. Acute Leukemia Group B.
JAMA; 1969 Feb; 207(5):923-8. PubMed ID: 4303512
[No Abstract] [Full Text] [Related]
33. Intravenous pegylated asparaginase versus intramuscular native Escherichia coli L-asparaginase in newly diagnosed childhood acute lymphoblastic leukaemia (DFCI 05-001): a randomised, open-label phase 3 trial.
Place AE; Stevenson KE; Vrooman LM; Harris MH; Hunt SK; O'Brien JE; Supko JG; Asselin BL; Athale UH; Clavell LA; Cole PD; Kelly KM; Laverdiere C; Leclerc JM; Michon B; Schorin MA; Welch JJ; Lipshultz SE; Kutok JL; Blonquist TM; Neuberg DS; Sallan SE; Silverman LB
Lancet Oncol; 2015 Dec; 16(16):1677-90. PubMed ID: 26549586
[TBL] [Abstract][Full Text] [Related]
34. Treatment of childhood acute lymphoblastic leukemia in Malaysia, 1976-1982.
Lin HP; Sinnah D; Menaka N; Cherian R; Singh P
Med Pediatr Oncol; 1983; 11(5):327-32. PubMed ID: 6579342
[TBL] [Abstract][Full Text] [Related]
35. Intermediate dose methotrexate in childhood acute lymphoblastic leukemia resulting in decreased incidence of testicular relapse.
Brecher ML; Weinberg V; Boyett JM; Sinks LF; Jones B; Glicksman A; Holland JF; Freeman AI
Cancer; 1986 Sep; 58(5):1024-8. PubMed ID: 3524797
[TBL] [Abstract][Full Text] [Related]
36. [Therapeutic management of remissions in acute lymphoblastic leukemia in children].
Armata J
Pol Tyg Lek; 1970 Nov; 25(44):1670-2. PubMed ID: 4921264
[No Abstract] [Full Text] [Related]
37. Pharmacokinetics of low-dose methotrexate in children receiving maintenance therapy for acute lymphoblastic leukaemia.
Pinkerton CR; Welshman SG; Kelly JG; Shanks RG; Bridges JM
Cancer Chemother Pharmacol; 1982 Dec; 10(1):36-9. PubMed ID: 6961972
[TBL] [Abstract][Full Text] [Related]
38. Acute lymphoblastic leukaemia: cyclical chemotherapy with three combinations of four drugs (COAP-POMP-CART regimen).
Spiers AS; Roberts PD; Marsh GW; Parekh SJ; Franklin AJ; Galton DA; Szur ZL; Paul EA; Husband P; Wiltshaw E
Br Med J; 1975 Dec; 4(5997):614-7. PubMed ID: 1060502
[TBL] [Abstract][Full Text] [Related]
39. [Which is the best methotrexate schedule for maintenance therapy of childhood ALL? A randomized study].
Wehinger H; Gutjahr P; Hofweber K; Imm W; Jacobi H; Jobke A; Langermann HJ; Lasson U; Nawrath H; Nessler G; Schenck W; Streitberger W
Klin Padiatr; 1982; 194(4):214-8. PubMed ID: 6752558
[TBL] [Abstract][Full Text] [Related]
40. Complication of methotrexate-maintained remission in lymphoblastic leukemia.
Rawbone RG; Shaw MT; Jackson JG; Bagshawe KD
Br Med J; 1971 Nov; 4(5785):467-8. PubMed ID: 5315979
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
